Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Agile Therapeutics, Inc. (Nasdaq: AGRX) will present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, at 9:10 a.m. ET. The conference will be held virtually, allowing broader access for participants.

A live webcast of the presentation will be available on Agile's Investor Relations page, and an archived version will remain accessible for 30 days. Agile focuses on women's healthcare and offers contraceptive solutions via its Twirla® transdermal system, allowing women flexibility in their contraceptive choices without the need for daily pills.

PRINCETON, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the Company will present at the 39^th Annual J.P. Morgan Healthcare Conference, which is being held virtually, on Thursday, January 14, 2021, at 9:10 a.m. ET.

A live webcast of the presentation will be available in the Events and Presentations section of the Agile Therapeutics Investor Relations page. The archived webcast will be available for 30 days.

About Agile Therapeutics, Inc.
Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women.  Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.  Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.

Follow Agile on LinkedIn and Twitter: @AgileTher.

Contact:  
Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com

FAQ

When will Agile Therapeutics present at the J.P. Morgan Healthcare Conference?

Agile Therapeutics will present on January 14, 2021, at 9:10 a.m. ET.

How can I access the Agile Therapeutics conference presentation?

The presentation will be available via a live webcast on Agile's Investor Relations page.

Is there a replay of Agile Therapeutics' conference presentation?

Yes, an archived version of the webcast will be available for 30 days after the event.

What is the focus of Agile Therapeutics?

Agile Therapeutics focuses on women's healthcare, providing non-daily contraceptive options.

What is Twirla® from Agile Therapeutics?

Twirla® is a non-daily prescription contraceptive that uses a transdermal patch for drug delivery.